Your session is about to expire
← Back to Search
Weight Management for Obesity
N/A
Waitlist Available
Led By Jodi S Holtrop, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year post intervention start cohort up till year 5 of the study
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at how well a weight-loss program works for patients, what factors help or hinder the program, and how the program affects the healthcare practice environment.
Who is the study for?
This trial is for adults over 18 years old with obesity, indicated by a BMI greater than 25 kg/m2. Participants must be receiving care at a primary care clinic involved in the study and affiliated with a participating practice.
What is being tested?
The PATHWEIGH study is testing a weight management program against usual care (control) in primary care settings. It looks at how well patients lose and maintain weight, factors affecting outcomes, and how practices adopt the program.
What are the potential side effects?
Since this trial involves weight management programs rather than medication or medical procedures, side effects are not typical as seen in drug trials but may include physical strain or psychological stress from lifestyle changes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I'm sorry, it seems like the description for the criterion is incomplete or missing. Could you please provide me with more information so I can summarize it for you?
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year post intervention start cohort up till year 5 of the study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year post intervention start cohort up till year 5 of the study
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evaluate the implementation of PATHWEIGH and determine its effectiveness versus control clinics using standard of care (SOC) on patient weight loss
Secondary study objectives
Evaluate the implementation of PATHWEIGH and determine its effectiveness versus standard of care on weight loss maintenance.
Other study objectives
Interventional procedure
Implementation - The intervention agents' fidelity to the various elements of the intervention's protocol including consistency of delivery as intended and the time and cost of the intervention
Maintenance - The extent to which the intervention becomes part of practice
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PATHWEIGHExperimental Treatment1 Intervention
A weight management care path that support primary care both through the EHR and training for the clinicians.
Group II: Standard of CareActive Control1 Intervention
Each primary care provider will administer weight loss care per their standard practice.
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,810 Previous Clinical Trials
2,820,100 Total Patients Enrolled
106 Trials studying Obesity
114,483 Patients Enrolled for Obesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,464 Previous Clinical Trials
4,237,453 Total Patients Enrolled
472 Trials studying Obesity
491,014 Patients Enrolled for Obesity
Jodi S Holtrop, PhDPrincipal InvestigatorUniversity of Colorado - Anschutz Medical Campus
Leigh Perreault, MDPrincipal InvestigatorUniversity of Colorado - Anschutz Medical Campus
1 Previous Clinical Trials
26 Total Patients Enrolled
1 Trials studying Obesity
26 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I care for patients who are 18 years old or older.You are overweight with a Body Mass Index (BMI) over 25 kg/m2.If you are interested in being a part of our study, please call and schedule an appointment with the clinic coordinatorI am over 18 years old.I'm sorry, it seems like the description for the criterion is incomplete or missing. Could you please provide me with more information so I can summarize it for you?, a patient is automatically enrolled in the health plan's patient-centered medical home (PCMH) program
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care
- Group 2: PATHWEIGH
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Obesity Patient Testimony for trial: Trial Name: NCT04678752 — N/A